Nursing Facility Assessments and Care Plans for Residents Receiving Atypical Antipsychotic Drugs. Executive Summary.

摘要

Elderly nursing facility residents (residents) receiving atypical antipsychotic drugs are a particularly vulnerable population because of an increased risk of death associated with these drugs. A previous Office of Inspector General (OIG) study found that when this population received these drugs, about half of the drugs were not given for medically accepted indications as required for Medicare coverage and one-fifth of the drugs were not given in accordance with Federal safeguards to protect nursing facility residents from unnecessary antipsychotic drug use. This study uses records collected for the previous study to assess the quality of the care provided by nursing facilities to residents receiving atypical antipsychotic drugs.